This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Coronary heart disease (myocardial infarction and stroke)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Stroke is a rare but potentially devastating complication of acute myocardial infarction

  • stroke occurs in approximately 1per cent of patients following percutaneous coronary intervention (PCI)
  • study evidence shows (1)
    • stroke occurred in 1.3% of primary patients with PCI
      • a third of strokes were ischemic (n=23; 33%), 12% (n=8) were hemorrhagic, and the remaining 55% (n=38) were of uncertain type
      • median (25th, 75th percentile) time of stroke occurrence was 6 (3, 14) days
      • 43% of strokes occurred within 48 hours of PCI, and all hemorrhagic strokes occurred within 48 hours
      • stroke was associated with an increased risk of 90-day death (unadjusted hazard ratio [HR], 8.0; 95% confidence interval [CI], 4.8-13.5), congestive heart failure (unadjusted HR, 3.2; 95% CI, 1.3-7.8), and 30-day hospital readmission (unadjusted HR, 3.2; 95% CI, 2.0-5.1)

    • all hemorrhagic strokes occurred within 48 hours of primary PCI, whereas ischemic strokes tended to occur beyond 48 hours
    • because most of the strokes occurred >48 hours after primary PCI, not all strokes after primary PCI seem to be procedure-related and, therefore, other mechanisms might be responsible for these later events


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.


Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.